ROBERT HAGEMANN - 31 Mar 2023 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role: Director
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Robert A. Hagemann (power of attorney previously filed)
Issuer symbol: ZBH
Transactions as of: 31 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2023, 16:15:25 UTC
Previous filing: 04 Jan 2023
Next filing: 02 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZBH	Phantom Stock Units	Award	$0	+263	+1%	$0.000000	25,733	31 Mar 2023	Common Stock	263	$128.51	Direct	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2	The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3	Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
F4	Includes 47.819 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.